ARTICLE | Company News
Alizyme, Norgine deal
October 26, 2009 7:00 AM UTC
Norgine acquired Alizyme's lead compound cetilistat for £4.6 million ($7.5 million) in cash, plus undisclosed milestones and royalties. The lipase inhibitor has completed Phase II testing for obesity...